Tygh Capital Management, Inc. - TRINITY BIOTECH PLC ownership

TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 92 filers reported holding TRINITY BIOTECH PLC in Q2 2014. The put-call ratio across all filers is 10.06 and the average weighting 0.3%.

Quarter-by-quarter ownership
Tygh Capital Management, Inc. ownership history of TRINITY BIOTECH PLC
ValueSharesWeighting
Q3 2015$2,008,000
-52.0%
175,500
-24.2%
0.48%
-36.4%
Q2 2015$4,179,000
+0.7%
231,382
+7.4%
0.75%
-2.1%
Q1 2015$4,148,000
+135.4%
215,459
+114.1%
0.76%
+124.0%
Q4 2014$1,762,000
+27.6%
100,629
+33.1%
0.34%
+12.9%
Q3 2014$1,381,000
-56.2%
75,586
-44.8%
0.30%
-55.0%
Q2 2014$3,153,000136,9200.67%
Other shareholders
TRINITY BIOTECH PLC shareholders Q2 2014
NameSharesValueWeighting ↓
ACK Asset Management 672,100$14,625,0005.62%
GOLDMAN CAPITAL MANAGEMENT INC 312,000$6,789,0004.48%
Lyon Street Capital, LLC 407,586$8,870,047,0004.37%
GREAT POINT PARTNERS LLC 189,071$4,114,0002.85%
Adirondack Research & Management Inc. 161,507$3,514,0002.02%
Park West Asset Management LLC 483,355$10,518,0001.56%
Benchmark Capital Advisors 56,954$1,239,0000.89%
WOODMONT INVESTMENT COUNSEL LLC 76,607$1,667,0000.61%
SHEPHERD KAPLAN KROCHUK, LLC 156,000$3,394,0000.55%
HEARTLAND ADVISORS INC 1,250,364$27,208,0000.50%
View complete list of TRINITY BIOTECH PLC shareholders